Legend
- Special session (13) (13)
- Mini Oral session (1) (1)
- Proffered Paper session (4) (4)
- Keynote lecture (1) (1)
- Expert selection (1) (1)
- Controversy session (4) (4)
- Young oncologists session (2) (2)
- Industry Satellite Symposium (11) (11)
Channel 1
Channel 2
Channel 3
Channel 4
Channel 5
Channel 6
- 08:00
- 09:00
- 10:00
- 11:00
- 12:00
- 13:00
- 14:00
- 15:00
- 16:00
- 17:00
- 18:00
- 19:00
-
Time12:45 - 13:15
-
Time15:05 - 16:05
-
Time16:20 - 17:20
-
Satellite NO Invitation Button (Conf Cal)Jazz Pharmaceuticals - Insight beyond Phase 3: does real-world evidence impact how we treat high-risk AML*? *High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
-
Time15:05 - 16:05
-
Time16:20 - 17:20
-
Satellite NO Invitation Button (Conf Cal)08:45 - 10:15 Boston Scientific - Expanding the treatment options for colorectal liver metastases with Y-90 radioembolisation: results of EPOCH study
-
Time13:30 - 14:05
-
Time14:20 - 14:55
-
Time16:20 - 16:55